Healthcare Roundup – Amgen files U.S. application for Rituxan biosimilar, Gilead files U.S. application for filgotinib Life Science
Healthcare Roundup – White House releases plan, Illumina to pay up to $34M to extend offer for Pacific Bio Life Science
Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody Life Science
Healthcare Roundup – Merck adds to aquaculture portfolio, CytoDyn out-licenses U.S. rights to leronlimab for HIV Life Science
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million Life Science
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure Life Science
Healthcare Roundup – U.S. approves Roche-Spark merger, Ad Com Tuesday for AstraZeneca’s Lynparza for maintenance of pancreatic cancer Life Science
Imperative Care Announces $85 Million Series C Financing for Innovative Stroke Treatments Life Science
Healthcare Roundup – Eagle Pharma on go to launch Alimta alternative，FDA clears Boston Scientific single-use duodenoscope Life Science
United Imaging’s Artificial Intelligence Subsidiary Wins in Facebook AI Research & NYU School of Medicine Global Competition Life Science
Healthcare Roundup – House passes drug pricing bill, Roche and Fortelinea to co-market software solutions Life Science
CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia Life Science
Zhejiang Medicine and Ambrx Present Positive Top Line Data from a Phase 1a/1b Clinical Trial of ARX788 in Metastatic HER2 Positive Breast Cancer Life Science
